KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aramark (ARMK) EBT (2016 - 2026)

Aramark (ARMK) has disclosed EBT for 15 consecutive years, with $135.6 million as the latest value for Q1 2026.

  • On a quarterly basis, EBT fell 4.12% to $135.6 million in Q1 2026 year-over-year; TTM through Jan 2026 was $424.7 million, a 6.45% decrease, with the full-year FY2025 number at $430.5 million, up 17.98% from a year prior.
  • EBT was $135.6 million for Q1 2026 at Aramark, up from $108.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $466.6 million in Q2 2023 to a low of -$108.7 million in Q3 2022.
  • A 5-year average of $97.8 million and a median of $82.3 million in 2024 define the central range for EBT.
  • Peak YoY movement for EBT: crashed 376.31% in 2022, then soared 727.02% in 2023.
  • Aramark's EBT stood at $50.7 million in 2022, then grew by 3.26% to $52.4 million in 2023, then surged by 170.02% to $141.5 million in 2024, then fell by 23.38% to $108.4 million in 2025, then increased by 25.14% to $135.6 million in 2026.
  • Per Business Quant, the three most recent readings for ARMK's EBT are $135.6 million (Q1 2026), $108.4 million (Q4 2025), and $96.2 million (Q2 2025).